Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiling Jiaogulan Powder (QLJP) is a Chinese herbal medicine formulation primarily investigated for its therapeutic effects in veterinary medicine, specifically in poultry. It is composed of herbal ingredients, including *Gynostemma pentaphyllum* (Jiaogulan). Research indicates that QLJP can alleviate pulmonary fibrosis and pulmonary arteriole remodeling in broilers exposed to low temperatures. Its mechanism of action involves the inhibition of the TGF-β1/Smad2 signaling pathway, leading to the downregulation of pro-fibrotic markers such as alpha-smooth muscle actin (α-SMA), collagen type I alpha 1 (COL1A1), and matrix metalloproteinase 2 (MMP2). By suppressing these pathways, QLJP helps maintain lung tissue integrity and prevents the development of pulmonary arterial hypertension in avian models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qiling Jiaogulan Powder.